Vietnam cooperates with WHO to address health priority issues
The Prime Minister has approved investment policy for a health cooperation programme with the World Health Organisation (WHO) in the fiscal year 2018-2019.
Taking care of patient at Bach Mai hospital in Hanoi (Photo VNA)
Hanoi (VNA) – The Prime Minister hasapproved investment policy for a health cooperation programme with the WorldHealth Organisation (WHO) in the fiscal year 2018-2019.
The programme, with financial support from theWHO, aims to help the Vietnamese Government tackle priority issues of thehealthcare system in the long run as well as successfully implement its strategyon improving public health care in 2016-2020 with a vision for 2030, and aproject on developing the grassroots healthcare network in 2016-2025.
In addition, the programme will strengthen the institutionsand the provision of human resources, finance, pharmaceuticals and health careservices to reduce household expenditure in the field while increasing the rateof doctors working at communal-level medical stations.
The scheme also targets stronger core capacity tocarry out the International Health Regulations (IHR), readiness to cope withurgent health issues, and effective use of WHO’s financial support for Vietnamto improve public health.
Another goal of the programme is to reduce therisk of communicable and non-communicable diseases such as HIV/AIDS, hepatitis,tuberculosis, and malaria.
It will be managed by the Ministry of Health ofVietnam with non-refundable official development assistance (ODA) of over 21.1million USD. Of the sum, 11.9 million USD is already available, another 9.1million USD will be mobilised from different sources, and counterpart capitalis 6.5 billion VND (287,950 USD).-VNA
More than 800 local and international cardiologists exchanged notes about the latest advances, new trends and innovative therapies for cardiovascular diseases at a congress in Ho Chi Minh City.
In order to reduce pressure placed on central hospitals, the basic medical services package at commune-level medical facilities will be implemented from December 2017.
The Vietnam Medicine Association and the Ministry of Health raised the fact that non-communicable diseases (NCDs) are now a leading cause of death in Vietnam at the sixth National Scientific Conference in Hanoi on November 21.
Prime Minister Nguyen Xuan Phuc has applauded achievements recorded by the Vietnam National Institute of Ophthalmology (VNIO), known as the Central Eye Hospital, especially the efforts made by it and the World Health Organisation (WHO) to eradicate trachoma in Vietnam.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.